Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

about

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

Item

http://www.wikidata.org/entity/Q47729981

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@en

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@nl

type

Item

label

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@en

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@nl

prefLabel

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@en

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@nl

P1476

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

@en

P2093

Evgeny A Bistrika

http://www.w3.org/2001/XMLSchema#string

William J Elliott

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries.

Atenolol in hypertension: is it a wise choice?

Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial.

P304

207-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2018.1397129

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29065722

http://www.w3.org/2001/XMLSchema#string